Staging of non-small lung cancer (NSCLC) uses the TNM classification and is undertaken to
identify those patients who are surgical candidates, either initially or after chemo …

Imaging plays a vital role in the management of non-small cell lung cancer including
diagnosis, staging and follow-up. CT and magnetic resonance imaging (MRI) are used in …

The staging of non-small lung cancer has to be performed in an interdisciplinary approach
considering all clinical, radiological and histologic results. The staging using imaging …

Lung cancer is a common malignancy and remains the leading cause of cancer-related
deaths in both men and women in the United States. Imaging plays an important role in the …

Patients with newly diagnosed non-small cell lung cancer (NSCLC) need accurate tumor
staging in order to direct appropriate therapy and establish prognosis; the tumor is usually …

Despite improvements in diagnosis and treatment, lung cancer remains one of the leading
causes of death in the United States and worldwide. It is estimated that in the United States …

Accurate evaluation of disease extent is mandatory when the diagnosis of resectable lung
cancer is established. Staging has a significant impact on subsequent therapeutic options …

Accurate clinical staging is critical in the evaluation of any patient with non-small cell lung
cancer (NSCLC). Staging for NSCLC is based on the tumor, node, metastasis (TNM) system …

The International Staging System developed by the Task Force on Lung Cancer of the
American Joint Committee on Cancer (AJCC) was introduced in 1986 [2-5]. The extent of …

Lung cancer is the most common type of cancer and the leading cause of cancer deaths in
the United States for both men and women. It was estimated that 173,770 new cases and …